Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-08-09 | New | $84,000,000 | $84,000,000 | Equity Only | 06b | SEC link |
| 2022-11-22 | Amended | $35,299,237 | $31,280,607 | Equity Only | 06b | SEC link |
| 2022-10-13 | New | $0 | $0 | Equity Only | 06b | SEC link |
| 2022-10-13 | New | $0 | $0 | Equity Only | 06b | SEC link |
| 2021-08-13 | New | $0 | Unknown | Equity Only | SEC link | |
| 2021-06-28 | New | $0 | $0 | Equity Only | 06b | SEC link |
| 2021-03-25 | New | $4,018,630 | $4,018,630 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Shelley Chu | Director |
| Sergio Duron | Director, Executive |
| Jay Lichter | Director |
| Sanford Madigan | Executive |
| Marcos Milla | Director |
| Tighe Reardon | Executive |
| Stephen Squinto | Director |
| James Topper | Director |